Setting

Europe Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248390 | Pages: 193

Europe active pharmaceutical ingredients market was valued at $49.52 billion in 2021 and will grow by 7.3% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 95 tables and 69 figures, this 193-page report “Europe Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country. Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. Synthetic API • Branded Synthetic API • Generic Synthetic API Biotech API by Drug Type: • Monoclonal Antibodies • Recombinant Proteins • Vaccines • Other Biotech APIs Biotech API by Customer Base: • Innovative Biologic API • Generic Biosimilar API Biotech API by Expression Technology: • Mammalian Expression • Microbial Expression • Yeast Expression • Insect Expression • Other Expression Technologies HPAPI • Branded HPAPI • Generic HPAPI Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. Captive Manufacturing • Branded Captive API • Generic Captive API Merchant Manufacturing by Drug Type: • Branded Merchant API • Generic Merchant API Merchant Manufacturing by Drug Synthesis: • Merchant Synthetic API • Merchant Biotech API By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section. • Branded Prescription Drugs • Generic Prescription Drugs • OTC Drugs Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis, and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: AbbVie Inc. Astrazeneca Aurobindo Pharma Ltd. BASF Bayer AG Boehringer Ingelheim Catalent Inc. Dr. Reddy's Laboratories F. Hoffmann-La Roche GlaxoSmithKline plc Lonza Group Lupin Limited Merck & Co., Inc. Mylan NV Novartis International AG Pfizer Inc. Sanofi Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 9 1.1 Industry Definition and Research Scope 9 1.1.1 Industry Definition 9 1.1.2 Research Scope 10 1.2 Research Methodology 13 1.2.1 Overview of Market Research Methodology 13 1.2.2 Market Assumption 14 1.2.3 Secondary Data 14 1.2.4 Primary Data 14 1.2.5 Data Filtration and Model Design 15 1.2.6 Market Size/Share Estimation 16 1.2.7 Research Limitations 17 1.3 Executive Summary 18 2 Market Overview and Dynamics 21 2.1 Market Size and Forecast 21 2.1.1 Impact of COVID-19 on World Economy 22 2.1.2 Impact of COVID-19 on the Market 24 2.2 Major Growth Drivers 31 2.3 Market Restraints and Challenges 39 2.4 Emerging Opportunities and Market Trends 42 2.5 Porter’s Fiver Forces Analysis 46 3 Segmentation of Europe Market by Synthesis 50 3.1 Market Overview by Synthesis 50 3.2 Synthetic API 52 3.2.1 Branded Synthetic API 53 3.2.2 Generic Synthetic API 54 3.3 Biotech API 55 3.3.1 Biotech API by Drug Type 56 3.3.1.1 Monoclonal Antibodies 57 3.3.1.2 Recombinant Proteins 58 3.3.1.3 Vaccines 59 3.3.1.4 Other Biotech APIs 60 3.3.2 Biotech API by Category 61 3.3.2.1 Innovative Biologic API 62 3.3.2.2 Generic Biosimilar API 63 3.3.3 Biotech API by Expression Technology 64 3.3.3.1 Mammalian Expression 65 3.3.3.2 Microbial Expression 66 3.3.3.3 Yeast Expression 67 3.3.3.4 Insect Expression 68 3.3.3.5 Other Expression Technologies 69 3.4 HPAPI 70 3.4.1 Branded HPAPI 71 3.4.2 Generic HPAPI 72 4 Segmentation of Europe Market by Manufacturing Process 73 4.1 Market Overview by Manufacturing Process 73 4.2 Captive Manufacturing 75 4.2.1 Branded Captive API 76 4.2.2 Generic Captive API 77 4.3 Merchant Manufacturing 78 4.3.1 Merchant Manufacturing by Drug Type 79 4.3.1.1 Branded Merchant API 80 4.3.1.2 Generic Merchant API 81 4.3.2 Merchant Manufacturing by Drug Synthesis 82 4.3.2.1 Merchant Synthetic API 83 4.3.2.2 Merchant Biotech API 84 5 Segmentation of Europe Market by Therapeutic Application 85 5.1 Market Overview by Therapeutic Application 85 5.2 Infectious Diseases 87 5.3 Oncology 88 5.4 Ophthalmology 89 5.5 Cardiovascular Disorders 90 5.6 Central Nervous System 91 5.7 Pulmonary Disorders 92 5.8 Orthopedics 93 5.9 Other Applications 94 6 Segmentation of Europe Market by Drug Type 95 6.1 Market Overview by Drug Type 95 6.2 Branded Prescription Drugs 97 6.3 Generic Prescription Drugs 98 6.4 OTC Drugs 99 7 European Market 2021-2028 by Country 100 7.1 Overview of European Market 100 7.2 UK 103 7.3 France 105 7.4 Germany 107 7.5 Spain 109 7.6 Italy 111 7.7 Russia 113 7.8 Rest of European Market 115 8 Competitive Landscape 117 8.1 Overview of Key Vendors 117 8.2 New Product Launch, Partnership, Investment, and M&A 120 8.3 Company Profiles 121 AbbVie Inc. 121 Astrazeneca 123 Aurobindo Pharma Ltd. 128 BASF 131 Bayer AG 134 Boehringer Ingelheim 138 Catalent Inc. 143 Dr. Reddy's Laboratories 146 F. Hoffmann-La Roche 148 GlaxoSmithKline plc 150 Lonza Group 155 Lupin Limited 160 Merck & Co., Inc. 163 Mylan NV 166 Novartis International AG 169 Pfizer Inc. 172 Sanofi 177 Sun Pharmaceutical Industries Ltd. 180 Teva Pharmaceutical Industries Ltd. 183 Thermo Fisher Scientific 185 9 Investing in Europe Market: Risk Assessment and Management 187 9.1 Risk Evaluation of Europe Market 187 9.2 Critical Success Factors (CSFs) 190 Related Reports and Products 193
List Of Tables:
Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028 19 Table 2. World Economic Outlook, 2021-2031 23 Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 38 Table 4. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 42 Table 5. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 50 Table 6. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn 52 Table 7. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn 56 Table 8. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn 61 Table 9. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn 64 Table 10. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn 70 Table 11. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 73 Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn 75 Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn 79 Table 14. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn 82 Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 85 Table 16. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn 95 Table 17. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn 102 Table 18. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 104 Table 19. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 104 Table 20. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 104 Table 21. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 106 Table 22. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 106 Table 23. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 106 Table 24. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 108 Table 25. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 108 Table 26. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 108 Table 27. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 110 Table 28. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 110 Table 29. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 110 Table 30. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 112 Table 31. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 112 Table 32. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 112 Table 33. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn 114 Table 34. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn 114 Table 35. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn 114 Table 36. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2018-2028, $ bn 116 Table 37. AbbVie Inc.: Company Snapshot 121 Table 38. AbbVie Inc.: Product Portfolio 121 Table 39. AbbVie Inc.: Revenue, 2018-2020, $ bn 122 Table 40. Astrazeneca: Company Snapshot 123 Table 41. Astrazeneca: Revenue, 2018-2020, $ bn 124 Table 42. Aurobindo Pharma Ltd.: Company Snapshot 128 Table 43. Aurobindo Pharma Ltd.: Product Portfolio 129 Table 44. BASF: Company Snapshot 131 Table 45. BASF: Business Segmentation 132 Table 46. BASF: Revenue by Region 132 Table 47. Bayer AG: Company Snapshot 134 Table 48. Bayer AG: Business Segmentation 135 Table 49. Bayer AG: Revenue, 2018-2020, € bn 135 Table 50. Boehringer Ingelheim: Company Snapshot 138 Table 51. Boehringer Ingelheim: Business Segmentation in 2019 139 Table 52. Boehringer Ingelheim: Product Portfolio 139 Table 53. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion 140 Table 54. Boehringer Ingelheim: Revenue by Region in 2019 140 Table 55. Catalent Inc.: Company Snapshot 143 Table 56. Catalent Inc.: Business Segmentation in 2018 144 Table 57. Catalent Inc.: Product Portfolio 144 Table 58. Catalent Inc.: Revenue, 2018-2020, $ million 145 Table 59. Catalent Inc.: Revenue by Region in 2018 145 Table 60. Dr. Reddy's Laboratories: Company Snapshot 146 Table 61. Dr. Reddy's Laboratories: Business Segmentation 146 Table 62. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn 147 Table 63. F. Hoffmann-La Roche: Company Snapshot 148 Table 64. F. Hoffmann-La Roche: Business Segmentation 149 Table 65. GlaxoSmithKline: Company Snapshot 150 Table 66. GlaxoSmithKline: Business Segmentation 151 Table 67. GlaxoSmithKline: Product Portfolio 152 Table 68. GlaxoSmithKline: Revenue, 2018-2020, $ bn 153 Table 69. Lonza Group: Company Snapshot 155 Table 70. Lonza Group: Business Segmentation in 2018 156 Table 71. Lonza Group: Product Portfolio 156 Table 72. Lonza Group: Revenue by Region in 2018 157 Table 73. Lupin Limited: Company Snapshot 160 Table 74. Lupin Limited: Business Segmentation 160 Table 75. Merck & Co., Inc.: Company Snapshot 163 Table 76. Merck & Co., Inc.: Business Segmentation 163 Table 77. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 164 Table 78. Mylan NV: Company Snapshot 166 Table 79. Mylan NV: Revenue, 2017-2019, $ bn 167 Table 80. Novartis International AG: Company Snapshot 169 Table 81. Novartis International AG: Business Segmentation 169 Table 82. Novartis International AG: Revenue, 2017-2019, $ bn 170 Table 83. Pfizer Inc.: Company Snapshot 172 Table 84. Pfizer Inc.: Business Segmentation 173 Table 85. Pfizer Inc.: Product Portfolio 174 Table 86. Pfizer Inc.: Revenue, 2018-2020, $ bn 174 Table 87. Sanofi: Company Snapshot 177 Table 88. Sanofi: Business Segmentation 177 Table 89. Sanofi: Revenue, 2018-2020, $ bn 178 Table 90. Sun Pharmaceutical Industries Limited: Company Snapshot 180 Table 91. Teva Pharmaceutical Industries Ltd.: Company Snapshot 183 Table 92. Teva Pharmaceutical Industries Ltd.: Business Segmentation 184 Table 93. Thermo Fisher Scientific: Company Snapshot 185 Table 94. Risk Evaluation for Investing in Europe Market, 2021-2028 188 Table 95. Critical Success Factors and Key Takeaways 191
List Of Figures:
Figure 1. Research Method Flow Chart 13 Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16 Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028 18 Figure 4. Europe Active Pharmaceutical Ingredients (API) Market, 2021-2028, $ bn 21 Figure 5. Impact of COVID-19 on Business 24 Figure 6. Primary Drivers and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 31 Figure 7. GDP per capita in the World, 1960-2018, $ thousand 34 Figure 8. Leading Causes of Death in the World, 2019-2020, million 35 Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 36 Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 36 Figure 11. Primary Restraints and Impact Factors of Europe Active Pharmaceutical Ingredients (API) Market 39 Figure 12. Investment Opportunity Analysis 43 Figure 13. Porter’s Fiver Forces Analysis of Europe Active Pharmaceutical Ingredients (API) Market 46 Figure 14. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue 50 Figure 15. Contribution to Europe 2022-2028 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%) 51 Figure 16. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, $ bn 52 Figure 17. Europe Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, $ bn 53 Figure 18. Europe Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, $ bn 54 Figure 19. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, $ bn 55 Figure 20. Europe Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, $ bn 57 Figure 21. Europe Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, $ bn 58 Figure 22. Europe Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, $ bn 59 Figure 23. Europe Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, $ bn 60 Figure 24. Europe Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, $ bn 62 Figure 25. Europe Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, $ bn 63 Figure 26. Europe Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, $ bn 65 Figure 27. Europe Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, $ bn 66 Figure 28. Europe Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, $ bn 67 Figure 29. Europe Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, $ bn 68 Figure 30. Europe Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, $ bn 69 Figure 31. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, $ bn 70 Figure 32. Europe Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, $ bn 71 Figure 33. Europe Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, $ bn 72 Figure 34. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue 73 Figure 35. Contribution to Europe 2022-2028 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%) 74 Figure 36. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, $ bn 75 Figure 37. Europe Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, $ bn 76 Figure 38. Europe Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, $ bn 77 Figure 39. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, $ bn 78 Figure 40. Europe Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, $ bn 80 Figure 41. Europe Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, $ bn 81 Figure 42. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, $ bn 83 Figure 43. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, $ bn 84 Figure 44. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue 85 Figure 45. Contribution to Europe 2022-2028 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 86 Figure 46. Europe Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, $ bn 87 Figure 47. Europe Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, $ bn 88 Figure 48. Europe Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, $ bn 89 Figure 49. Europe Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, $ bn 90 Figure 50. Europe Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, $ bn 91 Figure 51. Europe Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, $ bn 92 Figure 52. Europe Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, $ bn 93 Figure 53. Europe Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, $ bn 94 Figure 54. Breakdown of Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue 95 Figure 55. Contribution to Europe 2022-2028 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 96 Figure 56. Europe Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, $ bn 97 Figure 57. Europe Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, $ bn 98 Figure 58. Europe Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, $ bn 99 Figure 59. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue 101 Figure 60. Contribution to Europe 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%) 102 Figure 61. Active Pharmaceutical Ingredients (API) Market in UK, 2018-2028, $ bn 103 Figure 62. Active Pharmaceutical Ingredients (API) Market in France, 2018-2028, $ bn 105 Figure 63. Active Pharmaceutical Ingredients (API) Market in Germany, 2018-2028, $ bn 107 Figure 64. Active Pharmaceutical Ingredients (API) Market in Spain, 2018-2028, $ bn 109 Figure 65. Active Pharmaceutical Ingredients (API) Market in Italy, 2018-2028, $ bn 111 Figure 66. Active Pharmaceutical Ingredients (API) Market in Russia, 2018-2028, $ bn 113 Figure 67. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2018-2028, $ bn 115 Figure 68. Growth Stage of Europe Active Pharmaceutical Ingredients (API) Industry over the Forecast Period 117 Figure 69. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars) 124
Selected Key Players: 
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)